Do patients in Poland have access to innovative treatment? Which therapeutic options can actually be called breakthroughs?
What is the role of immunotherapy and molecularly targeted therapies in cancer treatment? How can patients search for clinical trials? And what does a breakthrough in treatment really mean for patients?
We will answer these and many other questions in the next edition of The Point educational campaign “Breakthrough therapies. The key to the development of medicine “, which has already been published in Gazeta Wyborcza. The content partners of this year’s edition are: Łazarski University, Polish Coalition of Oncological Patients, Alivia Foundation and Nadzieja Foundation.
MedOnet became the media partner of the campaign.
On the opportunities and challenges related to breakthrough therapies, the following say:
Prof. Dariusz M. Kowalski
Prof. Joanna Chorostowska- Wynimko
Prof. Tadeusz Pieńkowski
Bow. Izabela Łasińska
And
Ministry of Health – Deputy Minister of Health, Marcin Czech
Lazarski University – Dr Jerzy Gryglewicz
Polish Cancer Patient Coalition – Aleksandra Rudnicka
Alivia Foundation – Wojciech Wiśniewski
The Hope Foundation – Joanna Konarzewska- Król
More at: wpunktozdrowiu.pl